Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Sheiner

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1993
The importance of modeling interoccasion variability in population pharmacokinetic analysesM O Karlsson, L B Sheiner
Clinical Pharmacology and Therapeutics|June 1, 1994
Estimating bioavailability when clearance varies with timeM O Karlsson, L B Sheiner
Clinical Pharmacology and Therapeutics|January 1, 1991
Population dose versus response of betaxolol and atenolol: a comparison of potency and variabilityN C Sambol, L B Sheiner
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1976
A general method for optimal drug dose computationL A Wheeler, L B Sheiner
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1985
Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squaresL B Sheiner, S L Beal
Drug Metabolism Reviews|January 1, 1984
Experience with NONMEM: analysis of routine phenytoin clinical pharmacokinetic dataL B Sheiner, T H Grasela
Clinical Chemistry|February 1, 1977
Delta check tables for the Technicon SMA 6 continuous-flow analyzerL A Wheeler, L B Sheiner
Annual Review of Pharmacology and Toxicology|June 3, 2000
Pharmacokinetic/pharmacodynamic modeling in drug developmentL B Sheiner, J L Steimer
American Journal of Clinical Pathology|July 1, 1979
Clinical estimation of creatinine clearanceL A Wheeler, L B Sheiner
Annual Review of Pharmacology and Toxicology|January 1, 1992
Population pharmacokinetics/dynamicsL B Sheiner, T M Ludden
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1993
The importance of modeling interoccasion variability in population pharmacokinetic analysesM O Karlsson, L B Sheiner
Clinical Pharmacology and Therapeutics|June 1, 1994
Estimating bioavailability when clearance varies with timeM O Karlsson, L B Sheiner
Clinical Pharmacology and Therapeutics|January 1, 1991
Population dose versus response of betaxolol and atenolol: a comparison of potency and variabilityN C Sambol, L B Sheiner
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1976
A general method for optimal drug dose computationL A Wheeler, L B Sheiner
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1985
Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squaresL B Sheiner, S L Beal
Drug Metabolism Reviews|January 1, 1984
Experience with NONMEM: analysis of routine phenytoin clinical pharmacokinetic dataL B Sheiner, T H Grasela
Clinical Chemistry|February 1, 1977
Delta check tables for the Technicon SMA 6 continuous-flow analyzerL A Wheeler, L B Sheiner
Annual Review of Pharmacology and Toxicology|June 3, 2000
Pharmacokinetic/pharmacodynamic modeling in drug developmentL B Sheiner, J L Steimer
American Journal of Clinical Pathology|July 1, 1979
Clinical estimation of creatinine clearanceL A Wheeler, L B Sheiner
Annual Review of Pharmacology and Toxicology|January 1, 1992
Population pharmacokinetics/dynamicsL B Sheiner, T M Ludden
Pageof 15